Warfarin pharmacokinetics and pharmacodynamics are not affected by concomitant administration of the long-acting GLP-1 receptor agonist polyethylene glycol loxenatide
Concomitant administration of PEX-168 and single-dose warfarin was well tolerated. PEX-168 had no effect on the pharmacokinetics or pharmacodynamics of warfarin.
Authors
- Jianzhong Shentu (ORCID: https://orcid.org/0000-0002-7293-9768)
- Guolan Wu (ORCID: https://orcid.org/0000-0003-3964-9168)
- Duo Lv
- Meihua Lin (ORCID: https://orcid.org/0000-0001-7616-7358)
- Huili Zhou (ORCID: https://orcid.org/0000-0002-3532-2355)
Publication Details
- Journal
- International Journal of Clinical Pharmacology and Therapeutics
- Published
- 2024-11-28
- DOI
- https://doi.org/10.5414/cp204510
- Citations
- 1
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.36